Quick Answer
DNA X, Inc. reported Total Revenue of $58.30 million for fiscal year 2024.
DNA X, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2024 | $58.30M | -37.7% |
| 2023 | $93.63M | +34.1% |
| 2022 | $69.83M | +28.0% |
| 2021 | $54.57M | -14.7% |
| 2020 | $63.99M | -45.0% |
| 2019 | $116.25M | -14.3% |
| 2018 | $135.66M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $16.21M | +7.9% | +44.9% |
| June 30, 2025 | $11.19M | -2.8% | -33.1% |
| March 31, 2025 | $16.72M | -0.3% | +11.3% |
| September 30, 2024 | $15.02M | -45.5% | +30.4% |
| June 30, 2024 | $11.52M | -57.1% | -31.4% |
| March 31, 2024 | $16.78M | -35.0% | -39.1% |
| September 30, 2023 | $27.57M | +34.5% | +2.7% |
| June 30, 2023 | $26.84M | +124.5% | +4.0% |
- DNA X, Inc. showed a decrease of -37.7% in Total Revenue compared to the prior fiscal year.
- Over the 2018–2024 period, DNA X, Inc.’s total revenue has declined by 57.0% (from $135.66 million to $58.30 million).
- The most recent figure is from DNA X, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: